3869-32-7

Usage

Uses

Used in Pharmaceutical Industry:
(6,11,16a)-9-Fluoro-6,11,21-trihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-pregna-1,4-diene-3,20-dione is used as an active pharmaceutical ingredient (API) for the development of drugs targeting various medical conditions. Its unique structure and functional groups allow it to interact with specific biological targets, making it a promising candidate for the treatment of diseases such as inflammation, autoimmune disorders, and certain types of cancer.
Used in Research and Development:
In the field of research and development, (6,11,16a)-9-Fluoro-6,11,21-trihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-pregna-1,4-diene-3,20-dione serves as a valuable tool for understanding the structure-activity relationships of steroidal compounds. It can be used to investigate the effects of structural modifications on biological activity, which can lead to the discovery of new drugs with improved efficacy and reduced side effects.
Used in Drug Metabolism Studies:
As the major metabolite of Triamcinolone acetonide, a widely used corticosteroid, (6,11,16a)-9-Fluoro-6,11,21-trihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-pregna-1,4-diene-3,20-dione plays a crucial role in drug metabolism studies. Understanding its formation, elimination, and potential biological activities can provide insights into the pharmacokinetics and pharmacodynamics of Triamcinolone acetonide, ultimately contributing to the optimization of its therapeutic use.
Chemical Properties:
(6,11,16a)-9-Fluoro-6,11,21-trihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-pregna-1,4-diene-3,20-dione is a white to off-white solid, which indicates its relatively high molecular weight and complex structure. This physical state also suggests that the compound may have limited solubility in water but could be more soluble in organic solvents, which is a common characteristic of steroidal compounds.